Fritextsökning
Innehållstyper
-
KI mörkade kritik
- ledningen påverkade oberoende experters utvärdering.
-
Swedish nanotech crosses the Atlantic
Genovis signs distribution agreement Finnzymes in US.
-
EU says yes to Roche drug
EU approves a first in class therapy for treatment of patients with moderate to severe form of rheumatoid arthritis.
-
Upphandlingsproffset: Brist på målsättning vanligaste misstaget
Vad krävs för att formulera ett vinnande anbud eller göra en lyckad upphandling? Få vet det bättre än Magnus Josephson, mångårig juridisk expert på offentlig up...
-
Bring talent to those in need
Ho ho ho, Christmas time is here again. So get busy decking the halls, perhaps not with assorted greenery, but with something of a more lasting value.
-
Lytix calls in cash
Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.
-
Vad händer på Pharma Outsourcing i år?
På onsdag är det dags för årets bästa event om att lägga ut forskning och tillverkning av läkemedel.
-
Vitamin D is mental health aid
Vitamin D can help stave off the mental decline that can affect people in old age, a study suggests.
-
Orexo opens doors eastwards
The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.
-
Measure blood sugar without finger pricking
The Danish entrepreneurial firm RSP Systems has developed a method to measure the blood sugar level in diabetes patients, simply by placing a fingertip on a sma...
-
Outsourcing viktigare för läkemedelsutveckling
Hur har andra bolag gjort och vilka möjligheter finns det? Det är några av frågorna man kan får svar på vid årets upplaga av Pharrma Outsourcing, säger Maria Er...
-
Einar Pontén, Managing Director, Merck Sequant
Why are you going to Scanlab+Biotech Forum?
-
Skanska bygger för innovation och kommersialisering
Nu ska Skanska bygga The Loop, en mötesplats för kommersialisering av forskning och innovation.
-
Clinical trials in large scale to Stockholm
Karolinska Trial Alliance, KTA, will open a medical clinical for clinical trials in Phases II-IV. The clinic will be able to accommodate up to 150 patients per ...
-
Väntar sig patent
Follicum får preliminärt godkännande från Europapatentverket.
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.
-
Atlas Antibodies flyttar till Forskaren – "Viktigt steg"
Bioteknikbolaget Atlas Antibodies flyttar sitt huvudkontor till Forskaren i Hagastaden.
-
Designar alternativ till antibiotika
Martina Kulén, Kemiska institutionen, Umeå universitet, har i sitt avhandlingsarbete arbetat med utveckling av antivirulens-molekyler mot två olika bakterier.
-
Recipharm launches into biologics manufacturing
Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.
-
Faster sales but less profits for Probi
The probiotic company increases its turnover, and the net results are twice as large as last year.
-
Medtech companies find new beam technique
The medtech companies Raysearch and Nucletron expand collaboration with two new solutions for radiation treatment planning.
-
Gedea får Horizon-pengar
Vill bli alternativ till antibiotika – Hoppas nå marknaden 2021.
-
Discovery of new role for leukemia gene
Martin Bergö and his colleagues have studied two gene variants that often occur in acute leukemias. One gene codes for the protein RAS, which accelerates cell d...
-
Acadia drug awarded
Acadia Pharmaceutical has got an award for a new treatment against Parkinson's disease.
BREAKING